Philips has introduced a new generation of wearable biosensors for early detection of deterioration of the patient’s clinical condition, including clinical surveillance for COVID-19.
Wearable
Digital health in phases 2 and 3 of COVID-19
Digital innovation can play a key role in managing phases two and three of the Coronavirus. Let’s see the main areas of application.